Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy

Conditions: Ureteral Calculi Interventions: Drug: Control group; Drug: Ningmitai capsule; Drug: Combined group (Ningmitai plus tamsulosin) Sponsors: Xintian Pharmaceutical Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials